90294501 - CIFI

Information

  • Trademark
  • 90294501
  • Serial Number
    90294501
  • Filing Date
    November 02, 2020
    4 years ago
  • Transaction Date
    August 22, 2022
    2 years ago
  • Status Date
    August 22, 2022
    2 years ago
  • Published for Opposition Date
    May 25, 2021
    3 years ago
  • Location Date
    July 20, 2021
    3 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    KON, ELISSA GARBER
  • Attorney Docket Number
    ARIMA-201
    Attorney Name
    Samantha C. Markley
    Law Office Assigned Location Code
    L60
  • Owners
Mark Drawing Code
4000
Mark Identification
CIFI
Case File Statements
  • GS0051: Diagnostic preparations for medical purposes; diagnostic preparations for humans for medical purposes; diagnostic preparations for medical and veterinary purposes, namely, diagnostic preparations, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances in the nature of reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; chemical, biochemical and biotechnological preparations for medical and veterinary purposes, namely, diagnostic reagents, enzymes and diagnostic reagents in the nature of buffer solutions for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances, in the nature of reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; kits containing preparations for medical and veterinary diagnostic purposes primarily consisting of diagnostic preparations for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in the nature of nucleic acids, proteins, macromolecules and biologically active substances, in the nature of reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing
  • GS0011: Reagents for scientific and research use; Enzymes for scientific and research use; Kits for scientific and research use, namely, kits for molecular biology and cell biology applications comprising enzymes for scientific and research purposes; Reagents for scientific and research use in the field of molecular biology and cell biology applications; Enzymes for scientific and research use in the field of molecular biology and cell biology applications; Reagents for scientific and research use for amplification of DNA; Reagent kits for amplification of DNA comprising at least one of enzymes, buffers, and nucleic acids for use in biotechnology fields for scientific and research purposes; Reagents for scientific and research use for use in nucleic acid sequencing for scientific and research purposes; Kits for use in nucleic acid sequencing, namely, kits for molecular biology and cell biology applications comprised of at least one of enzymes, buffers, and nucleic acids for scientific and research purposes; kits for molecular biological research, namely, sequencing kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors
  • GS0441: Gene analysis and sequencing as well as DNA analysis and sequencing for medical diagnostic purposes; gene analysis and sequencing as well as DNA analysis and sequencing for use in cancer diagnosis and treatment
  • GS0421: Scientific research services, namely, gene analysis and sequencing as well as DNA analysis and sequencing; scientific research services, namely, preparation of materials for gene analysis and sequencing as well as DNA analysis and sequencing
Case File Event Statements
  • 8/22/2022 - 2 years ago
    24 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 8/22/2022 - 2 years ago
    23 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 11/10/2021 - 3 years ago
    22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 11/8/2021 - 3 years ago
    21 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 11/8/2021 - 3 years ago
    20 - SOU EXTENSION 1 FILED Type: EXT1
  • 11/8/2021 - 3 years ago
    19 - TEAS EXTENSION RECEIVED Type: EEXT
  • 7/20/2021 - 3 years ago
    18 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 5/25/2021 - 3 years ago
    17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/25/2021 - 3 years ago
    16 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/5/2021 - 3 years ago
    15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/15/2021 - 3 years ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/15/2021 - 3 years ago
    13 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 4/15/2021 - 3 years ago
    12 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 4/15/2021 - 3 years ago
    11 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 4/15/2021 - 3 years ago
    10 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/14/2021 - 3 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/13/2021 - 3 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/13/2021 - 3 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/5/2021 - 3 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/5/2021 - 3 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 4/5/2021 - 3 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/5/2021 - 3 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/30/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 11/5/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP